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Abstract
Recent studies investigating the management of analgesia in childbirth have demonstrated that pain
relief can be started early in labor with no negative consequences. Also of particular importance are
studies showing that automated delivery of large boluses of diluted local anesthetic with opioids might
be more effective than continuous background infusion of these drugs in patient-controlled epidural
analgesia.
Introduction and context
Providing effective and safe analgesia during labor
remains an ongoing challenge, as demonstrated by
recent studies that looked into the optimal dose of
local anesthetic to be given, either into the epidural or
the intrathecal space, as well as the modality of its
administration and the rediscovered continuous
intrathecal administration of drugs. The more technically
savvy researchers have undertaken sophisticated studies
describing new ways of providing epidural analgesia by
automated delivery of boluses rather than by continuous
background infusion during patient-controlled epidural
analgesia (PCEA). Others have opted to test the use of
ultrasound to guide their way into the neuraxial spaces.
These are exciting times indeed in the field of obstetric
anesthesia.
The goal of this brief review is to guide providers of
obstetric anesthesia towards an understanding of how
these new findings can improve their clinical practice.
Research has provided new insights into the mechanisms
and management of analgesia in labor and has shed
more light on the timing of epidural labor analgesia, the
choice of local anesthetics, the pharmacogenetics of
opioids, and the use of spinal microcatheters, ultrasound
technology, and programmed boluses with PCEA.
Recent advances
Timing of epidural labor analgesia
One of the most important recent advances directly
influencing clinical practice has been the unequivocal
demonstration that provision of neuraxial analgesia
early in labor has distinct advantages for maternal
analgesia and satisfaction, with no negative impact on
mode of delivery; that is, the Cesarean section rate was
not influenced by early combined spinal-epidural (CSE)
[1] or epidural [2] analgesia. These findings create a real
paradigm shift for care providers and allow women to
benefit from early neuraxial analgesia. The idea that there
is ‘no need to wait for a cervical dilatation of at least
4c m ’ has finally made it through and has received full
media coverage [3].
Choice of local anesthetic
The choice of which drug or combination of drugs, via
what route, and in what manner remains a concern for
the clinician. In choosing the dose and volume of local
anesthetic for epidural labor analgesia, larger volumes of
more dilute solutions of bupivacaine have been recom-
mended [4]; bupivacaine 0.125% when compared to
bupivacaine 0.25% produced equivalent analgesia with a
25% reduction in dose (that is, only 50% increase in
volume).
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blocking effects of local anesthetics and their impact
on mode of delivery. Low concentrations of epidural
bupivacaine (0.0625%) for maintenance of labor
analgesia provide effective and cost-efficient analgesia
(relative to ropivacaine and levobupivacaine) with
minor and inconsequential degrees of motor blockade
[5]. Similarly, for intrathecal analgesia in labor there
seems to be no benefit in substituting racemic bupiva-
caine with ropivacaine or levobupivacaine in combina-
tion with sufentanil [6].
Therefore, in the era of combined CSE and low-dose
PCEA infusions, bupivacaine undoubtedly remains the
choice for initiation of analgesia intrathecally or in dilute
epidural solutions, as well as for maintenance of labor
analgesia.
Pharmacogenetics
Pharmacogenetics, or the study of how genes impact
on the response to drugs, offers the potential to tailor
medications to each individual’s genetic profile. Many
anesthesiologists wonder about the relevance of genetic
research to modern anesthesiology, and often ask: ‘What
impact does this have on my everyday care of patients? I
usually titrate all drugs to effect anyway.’
Some insight has been given into the genetic component
of the analgesic response to intrathecal opioids given in
labor. While the way to routine genetic testing to guide
analgesic therapy is still a long one, a true pharmaco-
genetic effect of the μ-opioid receptor gene has been
demonstrated that explains differences in analgesic
requirements observed routinely in obstetric anesthesia
practice. A significant increase in sensitivity to the
analgesic effect of intrathecal fentanyl in laboring
women carrying a common variant of the μ-opioid
receptor gene was shown [7]. This demonstration of
a 1.5- to 2-fold difference in analgesic requirement
according to genotype is clinically relevant, because
provision of optimal labor analgesia remains a chal-
lenge, with a need to reduce doses and minimize opioid-
related side effects.
If confirmed in other clinical settings and with other
opioids, use of μ-opioid receptor genotyping may
improve the provision of analgesia in the not-too-distant
future.
Spinal microcatheters
Unfortunately, because spinal microcatheters (27–29
gauge) were associated with a cluster of cauda equina
syndrome in the United States in the early 1990s they
were banned by the US Food and Drug Administration
(FDA). Several years later, the FDA authorized a large
multicenter study with the challenging goal of investigat-
ing the safety of continuous intrathecal labor analgesia
with microcatheters. The recently published results of
this trial were able to refute the purported association
of this technique with neurologic injury [8]. However,
larger studies to evaluate the safety of continuous spinal
analgesia are still required before this technique can be
routinely utilized for the provision of labor analgesia.
The use of microcatheters has potential clinical implica-
tions, as it enables easily titratable use of intrathecal
analgesia in women with complex cardiac or pulmonary
diseases, or in women with previous spinal surgery
(laminectomy, fusion, Harrington rods) that might have
altered the integrity of the epidural space.
Regardless of whether microcatheters will find a real
place in the armamentarium of obstetric anesthesiolo-
gists, the main limitation on their widespread use is that
the European firm that produced the microcatheters for
the US trial has no plans to market them in the United
States. Meanwhile, a pediatric epidural kit available in
the United States that contains a 22-gauge epidural/
spinal needle with a 24-gauge epidural/spinal catheter
could be used to perform continuous intrathecal
analgesia and anesthesia in these special obstetric
patients.
Ultrasound technology
The rationale for using ultrasound to improve the
efficiency and safety of spinal and epidural analgesia/
anesthesia in obstetrics has been assessed. One investi-
gator [9] enthusiastically reported on the benefits of pre-
procedural ultrasonographic assessment of the lumbar
spine,which appears to provide valuable information for
the placement of spinals and epidurals and should help
manage high-risk women with challenging lumbar spine
anatomy. This enthusiasm might be dampened by
limitations such as the need for an assistant when real-
time ultrasound is sought or in the presence of morbid
obesity [10].
Programmed boluses with PCEA
Satisfaction with their treatment has been shown to
improve when women are offered the option to manage
their pain with a ‘push button’ and keep control of their
pain management [patient-controlled epidural analgesia
(PCEA)]. However, there is no consensus on an optimal
‘program’ for PCEA. In my opinion, one of the most
significant advances over recent years relates to the idea
that large boluses of diluted epidural solutions (local
anesthetic with opioids) rather than continuous infusion
of the same amounts of these drugs might provide better
spread of the infusate and therefore better sensory
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designed sophisticated studies using prototype pumps
to allow the automated delivery of ‘mandated’ boluses of
epidural solutions (local anesthetic with opioid, 5 ml
every 30 minutes) along with boluses self-administered
by the mother as wished [11–13]. This elegant drug-
delivery combination appears to achieve better analgesia
throughout labor, with lower amounts of local anes-
thetics being used overall and improved patient
satisfaction.
’High-tech’ algorithm-based computer-integrated PCEA
may one day provide the ultimate tailored labor
analgesia for those already convinced that CSE with
PCEA is the way to go [14]. It remains to be determined
how such prototypes will be applied in clinical practice,
bearing in mind factors such as reliability and cost of the
equipment versus the benefit in terms of a potential
reduction in anesthesia workload once the program is
running.
Implications for clinical practice
The most important contribution of recent obstetric
anesthesia research to clinical practice has been the
demonstration that early neuraxial labor analgesia does
not impact negatively on mode of delivery and obviously
improves maternal satisfaction. Modern clinical practice
should no longer make women requesting early labor
analgesia wait until a certain degree of cervical dilatation;
obstetrical anesthesiologists should be prepared to
educate women and general providers not aware of
these recent advances, and should obviously be ready to
provide early labor analgesia.
Other immediate applications relate to the choice of
rather larger doses of more dilute solutions of bupiva-
caine for initiation and maintenance of labor analgesia
using low-dose PCEA. The next generation of pumps
might allow automated delivery of ‘mandatory’ boluses
rather than background infusions to ensure a better
spread of the infusate, and perhaps utilize algorithm-
based computer-integrated PCEA programs.
Finally, for the more technically challenging cases, the
use of ultrasound guidance and continuous intrathecal
analgesia via microcatheter offer the potential to over-
come difficulties in neuraxial analgesia/anesthesia
placement.
Abbreviations
CSE, combined spinal-epidural; PCEA, patient-controlled
epidural analgesia.
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